Skip to content
  • Tuesday, 27 October 2026
  • 2:02 pm
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Gilead Sciences and Vir Biotechnology Expand Strategic Oncology Partnership in Multi-Billion-Dollar T-Cell Engager Deal for Solid Tumors
Pharmaceutical R&D

Gilead Sciences and Vir Biotechnology Expand Strategic Oncology Partnership in Multi-Billion-Dollar T-Cell Engager Deal for Solid Tumors

Teuku Ryan Oct 16, 2026 0

Gilead Sciences and Vir Biotechnology have significantly expanded their strategic research and development alliance through a newly finalized licensing agreement…

Read More
Pharmaceutical R&D

Perceptive Discovery and Nucleus RadioPharma Form Strategic Alliance to Streamline Radiopharmaceutical Development

Teuku Ryan Oct 13, 2026 0

The modern landscape of oncology and molecular imaging is undergoing a profound transformation, driven largely by the clinical promise of…

Read More
Pharmaceutical R&D

AstraZeneca and Daiichi Sankyo Join Forces with Summit Therapeutics in Strategic Clinical Partnership to Evaluate Novel Oncology Combinations

Teuku Ryan Oct 2, 2026 0

The oncology landscape is undergoing a significant strategic consolidation as major pharmaceutical players align their pipelines to maximize the therapeutic…

Read More
Pharmaceutical R&D

Novartis Secures Strategic Partnership with Abogen to Advance Novel T-Cell Engager Therapies in Autoimmune Disease

Teuku Ryan Oct 2, 2026 0

The landscape of pharmaceutical partnerships continues to evolve at a rapid pace, marked by strategic alliances designed to tackle complex…

Read More
Pharmaceutical R&D

Sandoz and mAbxience Forge Strategic Global Partnership to Develop and Commercialize Emicizumab Biosimilar for Haemophilia A

Teuku Ryan Sep 22, 2026 0

The global pharmaceutical landscape is undergoing a significant shift toward expanded accessibility for complex biologic therapies, highlighted by a major…

Read More
Pharmaceutical R&D

Eli Lilly and Partner QurCan Therapeutics Form Strategic Alliance to Advance Next-Generation Genetic Medicines for Nervous System Disorders

Teuku Ryan Sep 18, 2026 0

The landscape of genetic medicine took a significant stride forward as pharmaceutical giant Eli Lilly and Company joined forces with…

Read More
Pharmaceutical R&D

Exegenesis Bio and Modalis Therapeutics Join Forces in Strategic Licensing Agreement to Advance MDL-201 Gene Therapy for Duchenne Muscular Dystrophy

Teuku Ryan Sep 12, 2026 0

In a significant development for the field of genetic medicine, biotechnology innovators Exegenesis Bio and Modalis Therapeutics have formally announced…

Read More
Pharmaceutical R&D

Evogene and ELEO Forge Strategic Alliance to Pioneer Next-Generation Oral PCSK9 Inhibitors for Cardiovascular Disease

Teuku Ryan Jul 24, 2026 0

Evogene and ELEO have officially announced a significant scientific collaboration poised to accelerate the discovery and development of novel oral…

Read More
Pharmaceutical R&D

Samsung Biologics Accelerates Global Expansion with Strategic US Acquisition and PolyPeptide Deal

Teuku Ryan Jul 22, 2026 0

South Korean contract development and manufacturing organization (CDMO) Samsung Biologics has embarked on a significant phase of global expansion, marked…

Read More
Biotech & Genetic Research

Biotech Sector Sees Major Leaps in Multiomics, Cell Research Accessibility, and Strategic Leadership

Jia Lissa Jul 22, 2026 0

The global biotechnology landscape witnessed a week of pivotal advancements, marked by significant strides in multiomics research, enhanced accessibility to…

Read More

Posts pagination

1 2 … 5
Beyond the silver bullet: Why precision medicine is the next frontier for the $1 trillion obesity marketA Fresh Experiment Comes Up With a Lower Value for “Big G,” One of Physics’ Key ConstantsBreakthrough in Molecular Design of Viciazite Carbon Materials Enables Low-Temperature Carbon Dioxide Capture and Industrial SustainabilityThe biotech bi-weekly: partnerships facilitating antibody discovery and AI drug development
The Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals PlummetJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactEliquis Loss of Exclusivity: A Pharmaceutical Patent Cliff of Historic ProportionsMEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric Growth
2026 PharmSci 360 adds tracks on research credibility and post-animal drug development7 Advanced Python Design Patterns for Data ScientistsFrom Childhood Wonder to Smithsonian Curator: Gabriela Farfan’s Scientific Journey into the World of MineralsThe Architectural Evolution of Genius: How Ancient DNA Folding Unlocked the Intelligence of Cephalopods
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
2026 PharmSci 360 adds tracks on research credibility and post-animal drug development
Lana Keisha Oct 27, 2026
Data Science & Bioinformatics
7 Advanced Python Design Patterns for Data Scientists
Evan Lee Salim Oct 27, 2026
Environmental & Analytical Chemistry
From Childhood Wonder to Smithsonian Curator: Gabriela Farfan’s Scientific Journey into the World of Minerals
Abdurrohim Arsyad Oct 27, 2026
Molecular & Cell Biology
The Architectural Evolution of Genius: How Ancient DNA Folding Unlocked the Intelligence of Cephalopods
Angie Faith Oct 27, 2026

Copyright © 2026 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ